Cell killing of L1210 cells by cisplatin has been studied using flow cytometry and DNA gel electrophoresis. Ten hours after a supralethal dose of drug (100 tLM), extensive apoptosis was induced. Cells were also susceptible to the induction of apoptosis by nutritional deprivation, for example by incubation in arginine-deficient medium. After treatment in full medium with doses of drug in the range 1-1I0 M, cells experienced a slow-down in S-phase transit followed by a G2 block. Cells either overcame the G2 block and continued to cycle or enlarged and eventually died. There was no evidence to suggest that cells dying from the G2 block underwent apoptosis. The data were consistent with a dual mechanism of cell death -higher doses of drug led to rapid death through apoptosis; lower doses led to death at later times resulting from failure to overcome a block in G2.
The major cytotoxic lesion induced by cis-dichlorodiammineplatinum(II) (cisplatin) is considered to be platination of the DNA (Roberts & Thomson, 1979; Roberts & Friedlos, 1987) , leading to the introduction of interstrand (Roberts & Friedlos, 1987; Eastman, 1985) and predominantly intrastrand cross-links (Eastman, 1987) . The subsequent repair of such lesions is an important factor governing cytotoxicity (Fraval & Roberts, 1979; Meyn et al., 1982; Roberts & Friedlos, 1987; Sorenson & Eastman, 1988a) .
One of the early effects of the platination of DNA is a reduction in the rate of DNA synthesis (Fraval & Roberts, 1978; Salles et al., 1983; Sorenson & Eastman, 1988a ) and a consequent slow-down in the traverse of cells through the S-phase of their cycle; subsequently, there is a dosedependent arrest in G2 (Bergerat et al., 1979; Sorenson & Eastman, 1988a,b; Fujikane et al., 1989; Demarcq et al., 1992) . It has been proposed that in G2 the cells reach a point of decision at which they either overcome the G2 block, divide and then cycle or remain in G2 and die (Sorenson & Eastman, 1988a,b; Sorenson et al., 1990) .
Apoptosis is a mode of cell death believed to account for most or all of the programmed cell death responsible for tissue modelling in vertebrate development (for example see reviews by Wyllie et al., 1980; Arends & Wyllie, 1991; Wyllie, 1993) . It is characterised morphologically by condensation of nuclear chromatin, compaction of cytoplasmic organelles and changes in the cell surface Arends & Wyllie, 1991) . In many types of cell, particularly those of lymphoid origin, during apoptosis nuclear DNA is digested into oligonucleosomal length fragments (Wyllie, 1980) , although many morphological changes associated with apoptosis can be divorced from such DNA degradation (see, for example, Cohen et al., 1992; Tomei et al., 1993) . Recently it has been proposed that apoptosis might be an important and ubiquitous mode of cell death for cells treated with chemotherapeutic drugs Dive & Hickman, 1991; Hickman, 1992) . Treatment with cisplatin has been shown to induce apoptosis in Chinese hamster ovary and the L1210 murine leukaemia cell lines Sorenson et al., 1990) , and it has been postulated that cells blocked in G2 of the cell cycle die through apoptosis (Sorenson et al., 1990) .
A better understanding of the mechanism of drug-induced cytotoxicity is important since it would help in the design of more effective chemotherapeutic agents and treatment regimens. The purpose of this study was to use flow cytometry to re-examine the mechanism by which cisplatin kills cells and to explore the importance of apoptosis in cell death. (Ormerod, 1990 (Poot, 1990) . UV radiation was used for the flow cytometric analysis. After gating on a cytogram of peak vs area of the red fluorescent (PI-DNA) signal, a cytogram of red vs blue (Hoechst-DNA) fluorescence was recorded.
Materials and methods

Chemicals
DNA gel electrophoresis
Approximately 3 x 105 cells were centrifuged and the pellet resuspended in 30 pl of DNA lysis buffer (200 mM Tris, 100 mM EDTA, 1% SDS, pH 8.5). Proteinase K solution (3 ytl) at 1 mg ml-' was added and the mixture incubated at 37°C for 1 h. The mixture was incubated for a further hour after the addition of 6 il of RNAse solution at 1 mg ml-'. After the addition of 1 p1l of bromophenol blue solution and 20 1l of saturated sucrose, the mixture was passed twice through a 23-G needle to shear the DNA and then applied to the well of a horizontal 1% agarose gel. Electrophoresis was performed, using 90 mM Tris, 90 mM boric acid, 2 mM EDTA, 0.5 fig ml-' ethidium bromide, pH 8.0, as running buffer for 3h at 6Vcm-Cell size distribution Cell volume was measured using a Coulter counter (model ZB) coupled to a dedicated multichannel analyser (Mevway Electronics). Cell size distributions were produced using purpose-written software following calibration of the Coulter counter using latex beads of known volume.
Centrifugal elutriation A Beckmann J2-2 1 centrifuge equipped with a JE-6B elutriator rotor was used to separate the cell populations. Elutriations were performed with full culture medium at 4°C. Cells were loaded into the rotor at a flow rate of 13 ml minm-and rotor speed of 2,500 r.p.m.; under these conditions all cells larger than 250 ym3 were retained in the rotor chamber. The small cell fraction (250-1250 tm3) was then elutriated from the chamber by increasing flow rate to 35 ml min-'. This fraction was collected in a total of 300 ml to ensure maximal removal of cells of this size range. The remaining cells (the large cell fraction > 1250 tim3) were then collected from the chamber by switching off the rotor and collecting a single 100 ml fraction.
Results
Cell survival
As measured by colony formation, the IC50 for a 2 h incubation with cisplatin was 2.1 ± 0.33 jLM (six determinations; range 1.5-2.4 pM). A typical survival curve is shown in clearly evident, being almost complete at a dose of 10 pM. At longer times of incubation, the percentage of cells in G2 progressively reduced until, by 72 h, the cell cycle was close to that of normal cells. Typical histograms are shown in Figure 2 . If the light scatter of the fixed cells was observed, in untreated cells there was a single cluster but, at 24 h and later times after treatment with 1O JM cisplatin, a separate cluster of cells with higher light scatter appeared, being most apparent after 2 days (Figure 3 ). This cluster contained cells whose PI staining was greater (8%) than that of normal cells in G2. The abnormal cluster was from oversized cells; it was not caused by cell clumping since clumped cells could be identified on a plot of the peak vs the integrated PI fluorescence and were gated out.
Cell cycle analysis of live cells In order to observe the cell cycle of viable cells only, unfixed cells were incubated with the dye, Hoechst 33342, and PI added before analysis. PI would be taken up only by cells with damaged plasma membranes, that is dead cells. These were excluded from further analysis. The results confirmed that at later times there was a population of oversized cells in G2/M of the cell cycle and that the DNA of these cells took up more stain than normal cells in G2/M (Figure 4 ).
IAII. Cell cycle progression Cells were incubated continuously with BrdU and the permeabilised cells were stained with Hoechst 33352 and PI. The red (PI-DNA) fluorescence identified the cell cycle compartment, while the blue (Hoechst DNA) fluorescence was quenched by BrdU and identified those cells which had taken up the thymidine analogue (Rabinovitch et al., 1988) . A detailed description of this method applied to asynchronous cells has been given Ormerod and Kubbies (1992) . Figure 5 shows typical cytograms obtained from untreated cells. Without BrdU, GI, S and G2/M phases of the cell cycle could be identified from both the red (PI) and blue (Hoechst) fluorescence. After 3 h in BrdU, cells originally in G2/M had divided and moved into GI (unlabelled). Cells in S-phase showed increasing red fluorescence with cell cycle progression but no increase in blue fluorescence (quenched by the BrdU). At 8 h, all the cells now in S had been in GI at time 0 h (Sf on the figure) ; some had progressed as far as G2/M (G2f) and divided again (marked Gi'). There was a clear distinction between cells in GI which had divided after the addition of BrdU (29%) and those which were still in their first cycle. are shown in Figure Se and f) . At 8 h, most cells in G2 at the time of treatment had divided; some cells from late S-phase had progressed back to GI (9% of the total); cells treated in mid-and early S-phase were held up in late S/G2 and movement through S had slowed. By 24 h, nearly all the cells which had been in GI and G2M at time 0 had progressed through S and become blocked in G2 (G2f: 62% of the total). Most cells treated in mid-and late S-phase had overcome any G2 block and divided. (Cells treated in S phase which had become blocked in G2 would have been to the right of the position marked G2f in Figure Sf. ) If the BrdU was added 24h after treatment with 1O gM cisplatin, only cells which had escaped the block in G2M took up BrdU and a clear separation was obtained between those cells which remained blocked in G2/M and those which cycled normally (Figure 5g,h ). There was evidence that a minority of cells became blocked in G2 during their second cycle (cells lying to the left of the cluster, 'G2', and marked 'G2*' in the cytogram in Figure 5h Darzynkiewicz et al., 1992) , and this peak is closely associated both with the DNA degradation symptomatic of apoptosis ('DNA ladders'; Wyllie, 1980; Wyllie et al., 1980) and morphological changes typical of apoptosis Darzynkiewicz et al., 1992) . After doses of cisplatin of 20 ltM and below, following further incubation in drugfree medium up to 72 h, there was little evidence for a 'sub-GI' peak in the DNA histogram of for 'DNA ladders' on gel electrophoresis. Apoptosis, as evidenced by a sub-GI peak, DNA ladders and morphological changes, could be induced by doses of cisplatin O 50 tLM (25 x IC50) or by subjecting the cells to nutritional deprivation, such as incubation in arginine-deficient medium or incubation in PBS of cells which were in or close to the plateau phase of growth (Figure 6 ). The amount of apoptosis in untreated cells induced by deprivation of nutrients was variable and appeared to depend on the conditions of growth (cell density, log vs plateau phase, Jiang et al., 1993). It was also enhanced if the cells had previously been treated with 10 tLM cisplatin.
Separation of small and large cells
The marked difference in size between cells blocked in G2/M and cycling cells enabled them to be separated by centrifugal elutriation. The larger cells could be seen in the cell size distribution measured on a Coulter counter. Based on this distribution, a cut-off was set at 13.5 jim diameter on the elutriator and the cells separated into large and small fractions. The individual fractions were then incubated in growth medium for a further 3 days (a total of 5 days after drug treatment). The DNA histograms recorded from cells before and after centrifugal elutriation showed that a separation between cells blocked in G2 and cycling cells had been obtained (Figure 7) . The large cells (those blocked in G2) disappeared from the culture over 2 days, leaving cycling cells. The fraction of small cells consisted predominantly of normal cycling cells; an increase in G2/M after 1 day suggested that a minority of the cells were held up in G2 ( Figure  7e ). A sub-GI peak was not evident in the DNA histogram and, when samples were taken for DNA gel electrophoresis, a faint DNA ladder could be discerned only in the sample from small, cycling cells at day 5 (Figure 8b staining permeabilised cells with Hoechst 33352 and PI. The cell cycle phases are marked. G2* marks those cells in G2/M which were in S-phase at the time of addition of BrdU; Sf, cells which were initially in GI and had moved into S-phase; Gi', cells which had moved into GI after addition of BrdU and S' and G2' are cells in their second cycle. The numbers on the cytograms give the time in h after addition of BrdU. a-d, Untreated cells. e-h, Cells treated with 10 tM cisplatin for 2 h. e, f, BrdU added immediately after treatment and samples taken at 8 and 24 h. g, h, BrdU added 24 h after treatment and samples taken after a further 8 or 24 h incubation.
in both fractions was slower than that of untreated cells (Figure 8a) .
In some types of cell, apoptotic and necrotic cells can be simultaneously quantified after a brief incubation with the dye, Hoechst 33342, and addition of PI (Dive et al., 1992; Sun et al., 1992) . This method exploits a change in the permeability of the plasma membranes of apoptotic cells (Ormerod et al., 1993) . Preliminary experiments indicated that treatment of L1210 cells with the higher doses of cisplatin altered the permeability of non-apoptotic cells towards Hoechst 33342 and therefore this method was not pursued in this system.
Discussion
Cell cycle progression Our results clearly demonstrated that cells treated with cisplatin suffer a slow-down in the traverse of S-phase followed by a block in G2 -confirming previously published data. In agreement with the detailed kinetic study of Demarcq et al. (1992) , there was little, if any, hindrance of the transition from Gl into S phase and the division of cells treated in G2 was not affected. (This can be deduced from the lack of cells in the G2 compartment in Figure 5e .) Cells blocked in G2 after 24 h had incorporated BrdU and had therefore traversed S-phase after treatment. Cells treated in G2 divided and moved through S before any arrest in the subsequent G2, while cells treated in mid-and late S-phase had moved through the first G2 and divided. These deductions can be made by comparing Figure Sf with Figure 7C in Ormerod and Kubbies (1992) , which shows an example of cells, in S-phase during treatment, subsequently suffering a block on first reaching G2. In order to be arrested in G2, damage to DNA alone is insufficient; there must also be replication of DNA on the damaged template -an effect which has also been observed in cells treated with alkylating agents (Roberts, 1978) . It has been suggested that cells are more sensitive to cisplatin in GI (Roberts & Fraval, 1980) or at the GI/S boundary (Dornish et al., 1987) compared with S-phase. If the G2 block is a critical step in cell death, then our observation that cells treated in GI become blocked in G2 while those treated in S-phase move through G2 and divide is consistent with this suggestion. Our data also indicated that cells could be held up in G2 on the second cycle ( Figures 5 and 8 ).
Mechanism of cell death L1210 cells are susceptible to apoptosis, as evidenced by nutritional deprivation, and apoptosis was induced in L1210 cells by high doses of cisplatin (>50 gM) within 10 h of treatment (Figure 6; Barry et al., 1990) . The comparatively rapid induction of apoptosis contrasted with the slower rate of death associated with a G2 block.
At lower doses of cisplatin ( > 20 gLM), cells become blocked in G2. Our data are fully consistent with the suggestion that there is a major decision point at this stage of the cell cycle. The cells either eventually divide or stay in G2 and die (Sorenson et al., 1990 Figure 5 ). During this time (24-48 h), the cell number was nearly static (Figure 1 ), which might be expected if one population of cells was slowly dying and another was dividing. Our data also showed that each time the cell progressed through G2 the block/divide decision had to be repeated; a minority of cells were blocked in G2 on the second or third cycle (Figures 5 and 7e) . By DNA gel electrophoresis, we could find little evidence that the cells blocked in G2 died by apoptosis after doses of cisplatin >20gM. When the cells were separated by centrifugal elutriation, we did not observe significant DNA laddering in the large cell fraction, which presumably contained dying cells (Figure 8 ). Care has to be taken in interpreting this result since the number of apoptotic cells at any given time will depend on the balance between the rate of appearance and rate of loss, that is if the rate of induction of apoptosis is lower than the rate of disintegration of apoptotic cells then the latter would not be observed. However apop- totic cells were sufficiently stable to allow their observation after either high doses of drug or nutritional deprivation ( Figure 6 ). Furthermore, Sorenson et al. (1990) were able to observe extensive apoptosis in L1210 cells between 2 and 4 days after treatment with cisplatin.
There is an apparent discrepancy between our data and those of Sorenson et al. (1990) . While we and they both observe apoptosis at high doses of cisplatin, they also reported death through apoptosis of cells blocked in G2 of the cell cycle after lower doses of drug. The resolution of this difference lies in our observation that the induction of apoptosis can be influenced by the growth conditions. Our cells were grown in HEPES-buffered RPMI-1640 medium plus 10% horse serum and had a doubling time of about 14 h. medium with 15% calf serum under 5% carbon dioxide and they have reported a cell doubling time of 24 h (Sorenson & Eastman, 1988a) . Under suboptimal conditions for growth, it is possible that apoptosis was favoured.
Summary
We have confirmed that doses of cisplatin > 25 x IC50 rapidly induce apoptosis in L1210 cells. At lower doses of cisplatin, cell death was caused by a failure of cells to overcome a block in G2 of the cell cycle. While L1210 cells are susceptible to the induction of apoptosis by other treatments, we could find no evidence that they died from a G2 block, induced by cisplatin, by this mechanism.
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